Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

Clinical heterogeneity, a hallmark of systemic autoimmune diseases, impedes early diagnosis and effective treatment, issues that may be addressed if patients could be classified into groups defined by molecular pattern. This study was undertaken to identify molecular clusters for reclassifying systemic autoimmune diseases independently of clinical diagnosis.

E. Ballestar | J. Wojcik | Javier Martín | M. Alarcón‐Riquelme | M. González-Gay | J. Kageyama | N. Barbarroja | M. Martínez-Bueno | J. Pers | A. Saraux | V. Devauchelle-Pensec | S. Hayat | L. Kovács | C. Vasconcelos | A. Garcia-Gomez | R. Lopez-Pedrera | G. Espinosa | R. Cervera | E. Carnero-Montoro | M. Acosta-Herrera | F. Hiepe | J. Rodríguez-Ubreva | L. Beretta | P. Meroni | C. Jamin | L. Laigle | G. Barturen | M. Kerick | M. Rodríguez-Maresca | S. Jousse-Joulin | J. Cremer | T. Witte | D. Cornec | C. Chizzolini | M. Hernandez-Fuentes | E. Dow | N. Hunzelmann | M. Brandão | F. Farinha | G. Stummvoll | N. Ortego | Y. Jiménez-Gómez | Q. Cheng | M. Lehner | E. D. Rinaldis | J. Frostegård | B. Lauwerys | P. Carmona-Sáez | Yves Renaudineau | E. Collantes-Estévez | R. Ortega-Castro | L. Khodadadi | R. Lories | M. Gerosa | T. Schioppo | R. Lesche | Pierre-Emmanuel Jouve | R. Aguilar-Quesada | R. Benschop | M. Zauner | S. Dulić | B. Rouvière | T. Rowley | Y. Ioannou | E. Ramon | Tianlu Li | K. Kniesch | A. Balog | S. Babaei | F. Català-Moll | Z. Makowska | Jordi Martorell-Marugán | Daniel Toro-Domníguez | M. Teruel | L. L. Lann | A. Buttgereit | Joerg Mueller | M. Juarez | Ian White | C. Marañón | Tania Gomes-Anjos | N. Varela | Francisco Javier Garrancho | A. López-Berrio | H. Navarro-Linares | I. Almeida | Nancy Azevedo | A. Campar | R. Faria | A. Marinho | Esmeralda Neves | A. Tavares | E. Trombetta | G. Montanelli | B. Vigone | D. Álvarez-Errico | R. Blanco-Alonso | A. Corrales-Martínez | F. Genre | R. López-Mejías | Sara Remuzgo | Begoña Ubilla-Garcia | I. Rodríguez-Pintó | E. Langhe | D. Belz | N. Baerlecken | M. Aguirre-Zamorano | M. Castro-Villegas | Isabel Díaz-Quintero | A. Escudero-Contreras | M. Fernández-Roldán | I. Jiménez-Moleón | E. Raya | C. Artusi | A. D. Groof | J. Ducreux | A. Maudoux | Q. Simon | M. Alvarez | A. Dufour | Donatienne Wynar | M. Bocskai | M. Deák | G. Kádár | V. Gerl | Silvia Thiel | Sambasiva Rao | C. Chamberlain | J. Marovac | Maria Orietta-Borghi | F. Mcdonald | D. Alvarez-Errico | A. López‐Berrio | H. Navarro‐Linares | Gaia Montanelli | M. Alarcón-Riquelme | R. Lopez‐Pedrera | Antonio Garcia-Gomez | Anne‐Lise Maudoux | Héctor Navarro‐Linares | Ana Tavares

[1]  I. Bruce,et al.  Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles , 2019, Arthritis Research & Therapy.

[2]  Nir Hacohen,et al.  The immune cell landscape in kidneys of patients with lupus nephritis , 2019, Nature Immunology.

[3]  M. Barnes,et al.  Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients , 2019, Annals of the rheumatic diseases.

[4]  M. Mingueneau,et al.  Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndrome , 2019, European journal of immunology.

[5]  Daniel Toro-Domínguez,et al.  Stratification of Systemic Lupus Erythematosus Patients Into Three Groups of Disease Activity Progression According to Longitudinal Gene Expression , 2018, Arthritis & rheumatology.

[6]  J. Ashworth,et al.  Role of C-Reactive Protein at Sites of Inflammation and Infection , 2018, Front. Immunol..

[7]  M. Alarcón‐Riquelme,et al.  Moving towards a molecular taxonomy of autoimmune rheumatic diseases , 2018, Nature Reviews Rheumatology.

[8]  D. Mattey,et al.  Anti-citrullinated protein antibody positive rheumatoid arthritis is primarily determined by rheumatoid factor titre and the shared epitope rather than smoking per se , 2017, PloS one.

[9]  Christophe Jamin,et al.  Multi-center harmonization of flow cytometers in the context of the European "PRECISESADS" project. , 2016, Autoimmunity reviews.

[10]  Teresa Domaszewska,et al.  tmod: an R package for general and multivariate enrichment analysis , 2016 .

[11]  M. Alarcón‐Riquelme,et al.  Genetics of systemic lupus erythematosus and Sjögren's syndrome: an update , 2016, Current opinion in rheumatology.

[12]  D. Isenberg,et al.  Mixed connective tissue disease—enigma variations? , 2016, Rheumatology.

[13]  Virginia Pascual,et al.  Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients , 2016, Cell.

[14]  J. Josse,et al.  missMDA: A Package for Handling Missing Values in Multivariate Data Analysis , 2016 .

[15]  K. Kalunian,et al.  Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study , 2016, Annals of the rheumatic diseases.

[16]  George Papadatos,et al.  Patterns of database citation in articles and patents indicate long-term scientific and industry value of biological data resources , 2016, F1000Research.

[17]  Constantin Polychronakos,et al.  Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases , 2016 .

[18]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[19]  Atul J. Butte,et al.  Variation in the Human Immune System Is Largely Driven by Non-Heritable Influences , 2015, Cell.

[20]  Benjamin J. Raphael,et al.  Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin , 2014, Cell.

[21]  P. Gregersen,et al.  MHC associations with clinical and autoantibody manifestations in European SLE , 2014, Genes and Immunity.

[22]  Zhuowen Tu,et al.  Similarity network fusion for aggregating data types on a genomic scale , 2014, Nature Methods.

[23]  Sandra Romero-Steiner,et al.  Molecular signatures of antibody responses derived from a systems biological study of 5 human vaccines , 2013, Nature Immunology.

[24]  T. Marquès-Bonet,et al.  DNA methylation contributes to natural human variation , 2013, Genome research.

[25]  D. Caramella,et al.  Rhupus syndrome: assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. , 2013, Autoimmunity reviews.

[26]  William N. Venables,et al.  Modern Applied Statistics with S , 2010 .

[27]  Sanford Weisberg,et al.  An R Companion to Applied Regression , 2010 .

[28]  Yu Liu,et al.  Gene Expression Variability within and between Human Populations and Implications toward Disease Susceptibility , 2010, PLoS Comput. Biol..

[29]  C. Wijbrandts,et al.  Synovial tissue heterogeneity in rheumatoid arthritis in relation to disease activity and biomarkers in peripheral blood. , 2010, Arthritis and rheumatism.

[30]  Lionel B Ivashkiv,et al.  Type I interferon: a new player in TNF signaling. , 2010, Current directions in autoimmunity.

[31]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[32]  M. McCarter,et al.  Hyalinized collagen in a dermatofibrosarcoma protuberans after treatment with imatinib mesylate , 2008, Journal of cutaneous pathology.

[33]  Virginia Pascual,et al.  A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. , 2008, Immunity.

[34]  T. Hothorn,et al.  Simultaneous Inference in General Parametric Models , 2008, Biometrical journal. Biometrische Zeitschrift.

[35]  Anne M Manicone,et al.  Matrix metalloproteinases as modulators of inflammation. , 2008, Seminars in cell & developmental biology.

[36]  M. Mayes,et al.  Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts. , 2006, Arthritis and rheumatism.

[37]  Xuejun Liu,et al.  Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. , 2004, The Journal of clinical investigation.

[38]  Virginia Pascual,et al.  Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.

[39]  G. Karypis,et al.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[40]  W A Wilson,et al.  International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. , 1999, Arthritis and rheumatism.

[41]  W. Su,et al.  Classification of morphea (localized scleroderma) , 1995, Mayo Clinic proceedings.

[42]  D. Alarcón-Segovia,et al.  Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. , 1989, The Journal of rheumatology.

[43]  D. Alarcón-Segovia,et al.  Mixed connective tissue disease: Some statements , 1982, Clinical Rheumatology.

[44]  H. Holman,et al.  Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). , 1972, The American journal of medicine.

[45]  A. Drosos,et al.  Preliminary diagnostic criteria for Sjögren's syndrome. , 1986, Scandinavian journal of rheumatology. Supplement.

[46]  Y. Li.  Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases , 2022 .